That the Refreshed 10 year Milestone Plan for the London Cancer Hub, to deliver a significant proportion of the world leading life-science district within ten years, as set out in Appendix B to the report, be approved. That the re-phased Delivery Masterplan, as set out at Appendix C to the report, be noted. That the future allocation of the remaining Strategic Investment Pot (SIP) funds to support delivery of the London Cancer Hub, as set out at Appendix D to the report, be approved.
Word for word from the decision Sutton published for this meeting.Source: moderngov.sutton.gov.uk
1.1The London Cancer Hub (LCH) is a flagship regeneration scheme that exemplifies the ‘Ambitious for Sutton’ aims by creating a world class life science campus at Belmont, driving economic growth and delivering high quality jobs for the Borough.
1.2In June 2020, the Strategy and Resources Committee delegated the authority to proceed with the next phases of The London Cancer Hub, focused on direct delivery of the Innovation Gateway. In the following months, Epsom & St Helier University Hospital NHS Trust’s Special Emergency Care Hospital proposal progressed and it is now in pre-application planning stages.
1.3This report sets out the anticipated future phases of delivery of the LCH, while acknowledging the impact and relationship of the Special Emergency Care Hospital (referred to as “the hospital” in this report) on the London Cancer Hub vision, and recognising the wider health benefits that the hospital will provide.
Report Page 1 Agenda Item 11 Page 58 The London Cancer Hub - 2021 update
Recommendations
2.1To approve the Refreshed 10 year Milestone Plan for the London Cancer Hub, to deliver a significant proportion of the world leading life-science district within ten years, as set out in Appendix B.
2.2To note the re-phased Delivery Masterplan (Appendix C).
2.3To approve future allocation of the remaining Strategic Investment Pot (SIP) funds to support delivery of the London Cancer Hub, as set out in Appendix D.
3 Background and Key information
3.1The London Cancer Hub (LCH) is a partnership created to transform Sutton’s life-science site into a world-leading district specialising in cancer research, drug discovery and innovation, to deliver real benefits to cancer patients and drive economic growth. The London Cancer Hub is managed by the London Borough of Sutton and the Institute of Cancer Research (underpinned by a Memorandum of Agreement, 2017), also supported by the Royal Marsden NHS Foundation Trust, the Greater London Authority, and Epsom & St Helier University Hospitals NHS Trust.
3.2The UK life science sector generates £80 billion turnover each year1. Laboratory work cannot be performed from home, demand is generated for these workspaces even throughout global pandemics. Despite rising vacancies in the real estate office space market over the past 18 months, the life science sector demand continues to outstrip supply. This is detailed in Medcity’s London Life Sciences Real Estate Demand Report 2021, enclosed as Appendix F. Medcity highlights the London Cancer Hub’s Innovation Gateway as one of only two key facilities in London offering space to meet this demand.
3.3The fully built-out LCH will contribute c.£1.2bn each year to the UK economy and will generate employment in STEM (science, technology, engineering and maths). More than 13,000 jobs in total – 7,000 permanent jobs at the Sutton site and 6,200 jobs during construction – are anticipated. A projected £13m uplift in business rates, significant transport improvements, and skills and educational benefits, are part of the portfolio of benefits to the borough and region.
Read every report as text, not just the decision
Pro opens the officer report behind each decision, searchable and quotable, across every council we cover.
We use a cookie to keep you signed in and run your free-paper allowance, and an optional one to count visits. You can accept all, or choose. Privacy & cookies
Necessary
Keeps you signed in and runs your free-paper allowance. Always on.
Always on
Analytics
Counts visits and which pages are used. First-party only, no advertising, never shared.